4Regeneration-associated macrophages：a novel approach to boost intrinsic regenerative capacity for axon regeneration1368-1371
7Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inlfammation following traumatic brain injury1379-1384
8Cell transplantation for the treatment of spinal cord injury- bone marrow stromal cells and choroid plexus epithelial cells1385-1388
9Harnessing neural activity to promote repair of the damaged corticospinal system after spinal cord injury1389-1391
11Function of pioneer neurons speciifed by the basic helix-loop-helix transcription factor atonal in neural development1394-1395
12Possible divergence of serum- and glucocorticoid-inducible kinase function in ischemic brain injury1396-1397
13Concepts and opportunities for repair in cerebral microvascular disease and white matter stroke1398-1400
14The pleiotropic effects of tissue plasminogen activator in the brain:implications for stroke recovery1401-1402
16The suppressor of cytokine signalling 2(SOCS2), traumatic brain injury and microglial/macrophage regulation1405-1406
17Anesthesia-induced neurotoxicity in an animal model of the developing brain：mechanism and therapies1407-1408
18Central CB2 receptors in inlfammation-driven neurodegeneration：dysregulation and therapeutic potential1409-1410
